Nurse-led quality initiative cuts hypoglycemia in ICU patients

Nurse-led quality initiative cuts hypoglycemia in ICU patients

(HealthDay)—Nurse-driven root cause analysis is associated with a substantial reduction in hypoglycemia in the intensive care unit, according to a study published in the August issue of in Critical Care Nurse.

Krista E. Shea, M.S.N., from Stamford Hospital in Connecticut, and colleagues conducted real-time analysis of each episode of (blood glucose level <60 mg/dL) occurring at a 16-bed critical care unit of a university-affiliated teaching hospital. The interdisciplinary team also evaluated patient risk factors and nursing interventions once root cause analysis was incorporated into daily practice.

The researchers found that the percentage of patients with hypoglycemia decreased substantially during the implementation period among both those without diabetes (6.15 to 3.78 percent) and with diabetes (13.14 to 7.23 percent). Among patients without diabetes, mean blood glucose level decreased during the implementation period; among patients with diabetes, it did not change significantly. Additionally, glucose variability (as measured by the coefficient of variation) decreased during the implementation period among patients without and with diabetes.

"By finding a process to drill down to a new level of detail regarding the variety of factors that can lead to hypoglycemia, nurses were able to examine their own practice and make relatively minor adjustments that produced positive results," the authors write.

More information: Abstract/Full Text

Copyright © 2019 HealthDay. All rights reserved.

Citation: Nurse-led quality initiative cuts hypoglycemia in ICU patients (2019, August 10) retrieved 4 May 2024 from https://medicalxpress.com/news/2019-08-nurse-led-quality-hypoglycemia-icu-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA approves first needle-free 'Rescue' drug for low blood sugar episodes

4 shares

Feedback to editors